Keywords: Norepinephrine; Microdialysis; Diet induced obesity; Norepinephrine transporter; Striatum; Food intake;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: HPA; hypothalamic pituitary adrenocortical axis; SERT; serotonin transporter; NET; norepinephrine transporter; DAT; dopamine transporter; CUMS; chronic unpredictable mild stress test; SPT; sucrose preference test; LH; learned helplessness; OFT; open field
Keywords: Mephedrone; New psychoactive substances; Monoamine; Receptors; Transporters; 2,3-DMMC; 2,3-dimethylmethcathinone; 2,4-DMMC; 2,4-dimethylmethcathinone; 3,4-DMMC; 3,4-dimethylmethcathinone; 3-MMC; 3-methylmethcathinone; 4-MA; 4-methylamphetamine; 4-MMC; 4-m
Keywords: Norepinephrine transporter; Obesity; Eating behaviour; Three-Factor Eating Questionnaire; Position emission tomography; C-11-MRB;
Keywords: ACTH; adrenocorticotrophic hormone; AD; antidepressant; DAT; dopamine transporter; DTT; di-thiothreitol; FST; forced swim test; ISH; in-situ hybridization; LMA; locomotor activity; mPFC; medial prefrontal cortex; NET; norepinephrine transporter; SERT; ser
Keywords: Norepinephrine transporter; Postural tachycardia syndrome; Epigenetics; Gene regulation; MeCP2; Histone modifications; Chromatin;
Keywords: Duloxetine; Dyskinesia; Norepinephrine transporter; OFF time; Serotonin transporter; Parkinson's disease;
Keywords: Kappa opioid receptor; Serotonin; Clearance; Serotonin transporter; Phosphorylation; Trafficking; 5-HT; 5-hydroxytryptamine (serotonin); Akt X; Akt inhibitor X (10-(4â²-(N-diethylamino)butyl)-2-chlorophenoxazine); Akt; protein kinase B/Akt; BNI; nor-bina
Keywords: MDMA; 3,4-methylenedioxymethamphetamine; NE; norepinephrine; FFA; free fatty acids; CNS; central nervous system; DEA; Drug Enforcement Administration; DA; dopamine; 5HT; serotonin; NET; norepinephrine transporter; DAT; dopamine transporter; SERT; serotoni
Keywords: ADHD; attention hyperactive disorder; AKT; protein kinase B; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; Bcl-2; B-cell lymphoma 2; BDNF; brain derived neurotrophic factor; Css; Steady state plasma concentration; D1; type 1 dopamine recept
Keywords: OCT; optical coherence tomography; SC; Schlemm's canal; TM; trabecular meshwork; C57; C57BL/6; IOP; intraocular pressure; DBG; Dulbecco's phosphate-buffered saline containing 5.5Â mM D-glucose; PBS; phosphate buffered saline; NET; norepinephrine transpo
Keywords: SUI; Stress urinary incontinence; DAT; dopamine transporter; SERT; serotonin transporter; NET; norepinephrine transporter; MDR1; multidrug resistance protein 1; P-gp; P-glycoprotein; Peripheral-selective noradrenaline reuptake inhibitor; 7-Aryl-1,4-oxazep
Keywords: Zinc deficiency; Social isolation; Elevated plus maze test; Forced swim test; Cerebral norepinephrine concentration; Norepinephrine transporter;
Keywords: CNS; central nervous system; CRH; corticotropin releasing hormone; CRHR1; corticotropin releasing hormone receptor type 1; irCRH; immune-reactive CRH; PET; positron emission tomography; SPECT; single photon tomography; fMRI; functional magnetic resonance
Keywords: 5-HT; 5-hydroxytryptamine, serotonin; CRF; corticotropin-releasing factor; HPA; hypothalamus-pituitary-adrenal; WHO; World Health Organization; DSM-5; Diagnostic and Statistical Manual of Mental Disorders 5; MOA; monoamine oxidase; VMAT; vesicular monoami
Keywords: [123I]-β-CIT; 123I-labelled 2b-carbomethoxy-3b-(4-iodophenyl) tropane; 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT; 5-hydroxytryptamine, serotonin; 5-HTT; serotonin transporter; ADHD; attention deficit hyperactivity disorder; AMPH; amphetamine; ATS; ampheta
Keywords: Tyrosine hydroxylase; Norepinephrine transporter; Vesicular monoamine transporter 2; Stellate ganglia; Chronic stress
Keywords: HPA-axis; hypothalamic-pituitary-adrenal axis; GR; glucocorticoid receptors; PND; post natal day; DAT; dopamine transporter; NET; norepinephrine transporter; Maternal separation; Methamphetamine; Conditioned place preference; Locomotor activity;
Keywords: 5-HT; serotonin; β-AR; β-adrenergic receptor; ALDH; aldehyde dehydrogenase; ATP; adenosine triphosphate; CHF; congestive heart failure; COMT; catechol-O-methyl-transferase; EMT; extraneuronal monoamine transporter; ERK1/2; extracellular signal-regulated
Keywords: DAT; dopamine transporter; NET; norepinephrine transporter; SERT; serotonin transporter; TM; transmembrane domain; EL; extracellular loop; IL; intracellular loop; o.w.w.; original wet weight; BCIP/NBT; 5-bromo-4-chloro-3-indolyl phosphate/nitro blue; CFT;
Keywords: ANOVA; analysis of variance; BCA; bicinchoninic acid; DA; dopamine; DAT; dopamine transporter; FEP; free energy perturbation; GABA; gamma-amino butyric acid; GAT; GABA transporter; HRP; horseradish peroxidase; IL3; intracellular loop 3; MD; molecular dyna
Keywords: Amphetamine; Endocannabinoids; Glutamate; Monoamines; Endogenous opioids; Pharmacology; 5-HT; serotonin; ACh; acetylcholine; ADHD; attention-deficit/hyperactivity disorder; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; BDNF; brain-derived n
Keywords: SERT; serotonin transporter; NET; norepinephrine transporter; DAT; dopamine transporter; NSS; neurotransmitter/sodium (Na+/Clâ) symporter; SSRI; selective serotonin reuptake inhibitor; NBD; nitrobenzoxadiazolealanine; NMM; N-methylmorpholine; NHS; N-hyd
Keywords: 5-HT; serotonin; 5-HTT; serotonin transporter; AMPH; d-amphetamine; ANOVA; analysis of variance; CCD; charge coupled device; COMT; catechol-O-methyltransferase; DA; dopamine; DAT; dopamine transporter; EDTA; ethylenediaminetetraacetic acid; GFAP; glial fi
Keywords: ADHD; Metabolism; Norepinephrine transporter; PET; Reboxetine,
Keywords: Norepinephrine transporter; In vivo voltammetry; Spontaneously hypertensive rat; Attention deficit/hyperactivity disorder; Orbitofrontal cortex
Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)
Keywords: Phenethylamines; Psychedelics; Receptor; Affinity; New psychoactive substances; 4-bromo-2,5-dimethoxyphenethylamine; 2C-B; 2,5-dimethoxy-4-methylthiophenethylamine; 2C-T-1; 2,5-dimethoxy-4-(β-methallyl)thiophenethylamine; 2C-T-3; 2,5-dimethoxy-4-isopropy
Responses of PKCε to cardiac overloads on myocardial sympathetic innervation and NET expression
Keywords: Protein kinase C; Sympathetic nerve; Norepinephrine transporter; Cardiac overload; Myocardial collagen; β1-adrenergic receptor;
Development of serotonin transporter reuptake inhibition assays using JAR cells
Keywords: JAR cells; Methods; Reuptake inhibitors; Serotonin transporter; 5-HT; serotonin; BAT; plasma membrane biogenic amine transporter; DA; dopamine; DAT; dopamine transporter; NE; norepinephrine; NET; norepinephrine transporter; SERT; serotonin transporter; SS
Fluorinated phenmetrazine “legal highs” act as substrates for high-affinity monoamine transporters of the SLC6 family
Keywords: New psychoactive substances; Legal high; Phenmetrazine; Monoamine transporter; Amphetamine; 5-HT; 5-hydroxytryptamine; DA; dopamine; DAT; dopamine transporter; FPM; fluorophenmetrazine; HEK293Â cells; human embryonic kidney cells; KHB; Krebs-HEPES-buffer;
18F-labeled norepinephrine transporter tracer [18F]NS12137: radiosynthesis and preclinical evaluation
Keywords: Fluorine-18; [18F]Selectfluor; NS12137; electrophilic substitution; norepinephrine transporter; NET;
[18F]Diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain
Keywords: DASB; (N,N-dimethyl-2-(2-amino-4-cyanophenylthio)benzyl-amine; (+)-McN5652; trans-1,2,3,5,6,10-<beta>-hexahydro-6-[4-(methylthio)phenyl-[pyrrolo-[2,1-<alpha>]isoquinoline; ADAM; 2-((2-((dimethylamino)methyl)-phenyl)thio)-5-iodo-phenylamine; 4-FADAM; (N,N-
Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT2A receptors
Keywords: 25D-NBOMe; 2-(2,5-dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine; 25E-NBOMe; 2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine; 25H-NBOMe; 2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine; 25I-NBOH; 2-(((4-iodo-2,5-dimethoxyphene
The central serotonin2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: Rationale and current status of research
Keywords: 5-HT; serotonin; 5-HT2BR; 5-HT2B receptor; AC; adenylate cyclase; APDs; antipsychotic drugs; cAMP; cyclic adenosine monophosphate; CNS; central nervous system; DA; dopamine; DAG; diacylglycerol; DARPP-32; DA and c-AMP-regulated phosphoproteins Mr 32Â kDa;
Cardiac 123I-mIBG scintigraphy is associated with freedom of appropriate ICD therapy in stable chronic heart failure patients
Keywords: ATP; anti-tachycardia pacing; β-AR; β-adrenergic receptors; CE; combined endpoint; CHF; chronic heart failure; H/M; heart-to-mediastinum; HR; hazard ratio; NE; norepinephrine; NET; norepinephrine transporter; NT-proBNP; N-terminal pro B-type natriuretic
Association of norepinephrine transporter gene polymorphisms in attention-deficit/hyperactivity disorder in Korean population
Keywords: ADHD; attention-deficit hyperactivity disorder; NET; norepinephrine transporter; K-ARS; Korean version of the ADHD Rating Scale; KEDI-WISC; Korean Educational Development Institute-Wechsler Intelligence Scale for Children; CPT; Continuous Performance Test
Impairment in the mesohippocampal dopamine circuit following exposure to the brominated flame retardant, HBCDD
Keywords: Asyn; alpha-synuclein; BFR; brominated flame retardants; COMT; catechol-O-methyltransferase; DAB; 3,3â²-diaminobenzidine; DAT; dopamine transporter; HBCDD; hexabromocyclododecane; MAO-B; monoamine oxidase-B; NET; norepinephrine transporter; PBDE; polybro
Investigation of piperazine benzamides as human β3 adrenergic receptor agonists for the treatment of overactive bladder
Keywords: β3-Adrenergic receptor agonist; Reverse amide; Pyrrolidine scaffold; Overactive bladder; Norepinephrine transporter;
Differential effects of neonatal SSRI treatments on hypoxia-induced behavioral changes in male and female offspring
Keywords: 5-HIAA; 5-hydroxyindole acetic acid; CS; conditioned stimulus; DA; dopamine; DAT; dopamine transporter; DOPAC; 3,4-dihydroxy-phenylacetic acid; EPM; elevated plus maze; ESC; escitalopram; FLX; fluoxetine; FST; forced swim test; GD; gestational day; HPLC;
Noradrenergic modulation of evoked dopamine release and pH shift in the mouse dorsal hippocampus and ventral striatum
Keywords: α2-AR; α2-adrenoceptor; ANOVA; analysis of variance; cf; carbon fiber; DiI; diaminobenzidine; DA; dopamine; DSP-4; N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine; FSCV; fast-scan cyclic voltammetry; NE; norepinephrine; NET; norepinephrine transporter; MFB
Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay
Keywords: Dopamine transporter; Norepinephrine transporter; Serotonin transporter; Fluorescent monoamine substrate; Designer drugs; Drug screening; 2C-B; 2,5-dimethoxy-4-bromophenethylamine; 4-FA; 4-fluoroamphetamine; 5-APB; 5-(2-aminopropyl)benzofuran; 25B-NBOMe;
Compartmental modeling of [11C]MENET binding to the norepinephrine transporter in the healthy human brain
Keywords: Norepinephrine; Norepinephrine transporter; Positron emission tomography; Parkinson's; Alzheimer's; Stress;
Rapid and sustained antidepressant properties of an NMDA antagonist/monoamine reuptake inhibitor identified via transporter-based virtual screening
Keywords: MAT; monoamine transporters; DA; dopamine; DAT; dopamine transporter; SERT; serotonin transporter; NET; norepinephrine transporter; SSRI; serotonin selective reuptake inhibitor; TCA; tricyclic antidepressant; NMDA; n-methyl-d-aspartate; TST; tail suspensi
Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats
Keywords: Parkinson's disease; l-DOPA; Dyskinesia; Serotonin transporter; Dopamine transporter; Norepinephrine transporter;
ReviewAge-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats
Keywords: Norepinephrine transporter; Dopamine beta hydroxylase; Prelimbic cortex; Lateral orbitofrontal cortex; Anterior cingulate cortex;
SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population
Keywords: Major depressive disorder; Norepinephrine transporter; SLC6A2 gene; Venlafaxine; Remission;
Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)
Keywords: Phenethylamines; Hallucinogens; Novel psychoactive substances; Receptor; Affinity; 25B-NBOMe; 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl] ethanamine; 25C-NBOMe; 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl] ethanamine; 25D-N
Imaging human brown adipose tissue under room temperature conditions with 11C-MRB, a selective norepinephrine transporter PET ligand
Keywords: Human brown adipose tissue; Norepinephrine transporter; (S,S)-11C-O-methylreboxetine; Positron emission tomography (PET); Sympathetic nervous system;
Association of norepinephrine transporter (NET, SLC6A2) genotype with ADHD-related phenotypes: Findings of a longitudinal study from birth to adolescence
Keywords: Attention-deficit/hyperactivity disorder; Norepinephrine transporter; Genetic association; Polymorphism; Molecular heterosis; Continuous performance task;
Life-long norepinephrine transporter (NET) knock-out leads to the increase in the NET mRNA in brain regions rich in norepinephrine terminals
Keywords: Norepinephrine transporter; Knock-out mice; Desipramine; Gene expression; Ago2 protein;